Abstract
Diabetes mellitus is a disorder resulting from a lost in control of blood glucose level by insufficient insulin release (type 1), impaired insulin function, or insulin resistance (type 2). The main etiology for mortality and a great percent of the morbidity in patients with diabetes is cardiovascular disease. In addition to hyperglycemia, enhanced oxidative stress plays a major role in the pathogenesis of diabetes. Although reactive oxygen species (ROS) are known to be mediators of intracellular signaling pathways under physiological conditions, excessive production of ROS can be detrimental to the cells as a result of increased oxidative stress and thereby cellular dysfunction. Hence, well-tuned, balanced, and responsive antioxidant systems are vital for proper regulation of the redox status of the cells. Studies have reported valuable effects of antioxidant agents, including trace elements, on diabetes-induced cardiovascular system dysfunctions, either directly or indirectly. Thus, several approaches have been carried out to either diminish an elevated ROS production or improve the endogenous levels of antioxidants. Indeed, reduced fatty acid oxidation and use of trace elements in treatment strategies result in promising prevention hints for diabetes-induced cardiovascular dysfunctions. Our scope here is to review the important role of antioxidants, particularly selenium, as cardioprotective agents in several types of disease states including diabetes, presenting our research results on cardiac function by using experimental animal models for diabetes. Although the paradigm that inhibiting overproduction of superoxides and peroxides would prevent cardiac dysfunction diabetes-induced damage has been difficult to verify using conventional antioxidants such as selenium, of special note is that its role as hyperglycemia controller, insulin sensitizer, or antioxidant therapy remains to be further explored as well as the effect of hypolipidemic therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organisation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf
Pierce GN, Russel JC (1997) Regulation of intracellular Ca2+ in the heart during diabetes. Cardiovasc Res 34:41–47
Xu Z, Patel KP, Lou MF, Rozanski GJ (2002) Up-regulation of K(+) channels in diabetic rat ventricular myocytes by insulin and glutathione. Cardiovasc Res 53:80–88
Ayaz M, Ozdemir S, Ugur M, Vassort G, Turan B (2004) Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys 426:83–90
Ayaz M, Turan B (2006) Selenium prevents diabetes-induced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle. Am J Physiol Heart Circ Physiol 290:H1071–H1080
Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213–3223
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2008) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2, CD007176
Ikegami H, Fujisawa T, Ogihara T (2004) Mouse models of type 1 and type 2 diabetes derived from the same closed colony: genetic susceptibility shared between two types of diabetes. ILAR J 45:268–277
Cooke DW, Plotnick L (2008) Type 1 diabetes mellitus in pediatrics. Pediatr Rev 29:374–384
Sicree R, Shaw J, Zimmet P, Tapp R (2003) The global burden of diabetes. In: Gan D (ed) Diabetes atlas 2003, 2nd edn. International Diabetes Federation, Brussels
Garcia MJ, McNamara PM, Gordon T, Kannel WB (1974) Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23:105–111
Consensus statement/American Diabetes Association (1993) Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care 16:72–78
Hayat SA, Patel B, Khattar RS, Malik RA (2004) Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 107:539–557
Rubler S, Dlugash J, Yuceoglu YZ et al (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595–602
Bell DS (1995) Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 18:708–714
Aneja A, Tang WH, Bansilal S et al (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121:748–757
Ferri C, Piccoli A, Laurenti O et al (1994) Atrial natriuretic factor in hypertensive and normotensive diabetic patients. Diabetes Care 17:195–200
Du XL, Edelstein D, Rossetti L et al (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222–12226
Witztum JL (1994) The oxidation hypothesis of atherosclerosis. Lancet 344(8925):793–795
Steinberg D (1992) Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop. Circulation 85:2337–2344
Roep BO, Atkinson M (2004) Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal. Diabetologia 47:1650–1656
Serreze DV, Chen YG (2005) Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans. Trends Immunol 26:603–607
Chen D, Wang MW (2005) Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab 7:307–317
Etuk EU (2010) Animal models for studying diabetes mellitus. Agric Biol J North Am 1:130–134
Chatzigeorgio A, Halapas A, Kalafatakis K, Kamper E (2009) The use of animal models in the study of diabetes mellitus. In Vivo 23:245–258
Le NN, Rose MB, Levinson H, Klitzman B (2011) Implant healing in experimental animal models of diabetes. J Diabetes Sci Technol 5:605–618
Hsueh W, Abel D, Breslow JL et al (2007) Recipes for creating animal models of diabetic cardiovascular disease. Circ Res 100:1415–1427
Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9
Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880
Aviram M (2000) Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res 33:S85–S97
Giugliano D, Ceriello A, Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19:257–267
Turan B (2010) Role of antioxidants in redox regulation of diabetic cardiovascular complications. Curr Pharm Biotechnol 11:819–836
Santos CX, Anilkumar N, Zhang M et al (2011) Redox signaling in cardiac myocytes. Free Radic Biol Med 50:777–793
Kowaltowski AJ, de Souza-Pinto NC, Castilho RF et al (2009) Mitochondria and reactive oxygen species. Free Radic Biol Med 47:333–343
St.-Pierre J, Buckingham JA, Roebuck SJ et al (2002) Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 277:44784–44790
Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1–13
Aon MA, Cortassa S, O’Rourke B (2010) Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta 1797:865–877
Zuurbier CJ, Eerbeek O, Goedhart PT et al (2004) Inhibition of the pentose phosphate pathway decreases ischemia–reperfusion-induced creatine kinase release in the heart. Cardiovasc Res 62:145–153
Balteau M, Tajeddine N, de Meester C et al (2011) NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1. Cardiovasc Res 92:237–246
Ceolotto G, Gallo A, Papparella I et al (2007) Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol 27:2627–2633
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058–1070
Forstermann U (2008) Oxidative stress in vascular disease: causes, defence mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 5:338–349
Tuncay E, Seymen AA, Tanriverdi E, Yaras N et al (2007) Gender related differential effects of Omega-3E treatment on diabetes-induced left ventricular dysfunction. Mol Cell Biochem 304:255–263
Kakkar R, Kalra J, Mantha SV, Prasad K (1995) Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 151:113–119
Okutan H, Ozcelik N, Yilmaz HR, Uz E (2005) Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem 38(2):191–196
Stockklauser-Farber K, Ballhausen T, Laufer A, Rosen P (2000) Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim Biophys Acta 1535:10–20
Zhen J, Lu H, Wang XQ, Vaziri ND, Zhou XJ (2008) Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens 21:28–34
Fiordaliso F, Li B, Latini R, Sonnenblick EH et al (2000) Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent. Lab Invest 80:513–527
Bendall JK, Cave AC, Heymes C, Gall N, Shah AM (2002) Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105:293–296
Griendling KK, Ushio-Fukai M (2000) Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91:21–27
Ricci C, Pastukh V, Leonard J, Turrens J et al (2008) Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am J Physiol Cell Physiol 294:C413–C422
Yaras N, Bilginoglu A, Vassort G, Turan B (2007) Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade. Am J Physiol Heart Circ Physiol 292:H912–H920
Privratsky JR, Wol LE, Sowers JR, Quinn MT, Ren J (2003) AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 42:206–212
Brown L, Wall D, Marchant C, Sernia C (1997) Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats. J Endocrinol 154:355–362
Shekelle PG, Rich MW, Morton SC, Atkinson CS et al (2003) Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol 41:1529–1538
Shimoni Y, Hunt D, Chuang M, Chen KY et al (2005) Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat. J Physiol 567:177–190
Raimondi L, De Paoli P, Mannucci E, Lonardo G et al (2004) Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats. Diabetes 53:1927–1933
Ding Y, Zou R, Judd RL, Zhong J (2006) Endothelin-1 receptor blockade prevented the electrophysiological dysfunction in cardiac myocytes of streptozotocin-induced diabetic rats. Endocrine 30:121–127
Shimoni Y, Chen K, Emmett T, Kargacin G (2008) Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart. Br J Pharmacol 154:675–687
Bilginoglu A, Kandilci HB, Turan B (2013) Intracellular levels of Na(+) and TTX-sensitive Na(+) channel current in diabetic rat ventricular cardiomyocytes. Cardiovasc Toxicol 13(2):138–147
Valdecantos MP, Pérez-Matute P, MartÃnez JA (2009) Obesity and oxidative stress: role of antioxidant supplementation. Rev Invest Clin 61:127–139
Campión J, Milagro FI, Fernández D et al (2006) Differential gene expression and adiposity reduction induced by ascorbic acid supplementation in a cafeteria model of obesity. J Physiol Biochem 62:71–80
Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M et al (2009) Lipoic acid prevents body weight gain induced by a high fat diet in rats: effects on intestinal sugar transport. J Physiol Biochem 65:43–50
Venditti P, Bari A, Di Stefano L et al (2007) Vitamin E attenuates cold-induced rat liver oxidative damage reducing H2O2 mitochondrial release. Int J Biochem Cell Biol 39:1731–1742
Dai J, Jones DP, Goldberg J et al (2008) Association between adherence to the Mediterranean diet and oxidative stress. Am J Clin Nutr 88:1364–1370
Crujeiras AB, Parra MD, RodrÃguez MC et al (2006) A role for fruit content in energy-restricted diets in improving antioxidant status in obese women during weight loss. Nutrition 22:593–599
Roman M, Lapolla A, Jitaru P, Sechi A et al (2010) Plasma selenoproteins concentrations in type 2 diabetes mellitus—a pilot study. Transl Res 156:242–250
Neve J (1996) Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk 3:42–47
Xia Y, Hill KE, Li P, Xu J, Zhou D et al (2010) Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects. Am J Clin Nutr 92:525–531
Brown BG, Zhao XQ, Chait A, Fisher LD et al (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583–1592
Faure P, Ramon O, Favier A, Halimi S (2004) Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. Eur J Clin Invest 34:475–481
Xia Y, Hill KE, Byrne DW, Xu Ji Burk RF (2005) Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 81:829–834
Rayman MP (2000) The importance of selenium to human health. Lancet 356:233–241
Faure P (2003) Protective effects of antioxidant micronutrients (vitamin E, zinc and selenium) in type 2 diabetes mellitus. Clin Chem Lab Med 41:995–998
Stranges S, Marshall JR, Trevisan M, Natarajan R et al (2006) Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol 163:694–699
Bleys J, Navas-Acien A, Guallar E (2007) Serum selenium and diabetes in U.S. adults. Diabetes Care 30:829–834
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 54(9177):447–455
Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J et al (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338–1347
Maritim AC, Sanders RA, Watkins JB (2003) Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 14:288–294
Iwata K, Nishinak T, Matsuno K, Kakehi T, Katsuyama M et al (2007) The activity of aldose reductase is elevated in diabetic mouse hart. J Pharmacol Sci 103:408–416
Kakkar R, Mantha SV, Kalra J, Prasad K (1996) Time course study of oxidative stress in aorta and heart of diabetic rat. Clin Sci (Lond) 91:441–448
Guo Z, Xia Z, Jiang J, McNeill JH (2007) Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine. Am J Physiol Heart Circ Physiol 292:H1728–H1736
Xia Z, Guo Z, Nagareddy PR, Yuen V, Yeung E, McNeill JH (2006) Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats. Eur J Pharmacol 544:118–125
Jain SK, McVie R (1999) Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 49: 1850–1855
De Mattia G, Bravi MC, Laurenti O et al (1998) Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes. Diabetologia 41:1392–1396
González-Ordóñez AJ, Fernández-Carreira JM, Fernández-Alvarez CR et al (2003) The concentration of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism. Haematologica 88:1035–1043
Diaz MN, Frei B, Vita JA et al (1997) Antioxidants and atherosclerotic heart disease. N Engl J Med 337:408–416
Voloshyna I, Hussaini SM, Reiss AB (2012) Resveratrol in cholesterol metabolism and atherosclerosis. J Med Food 15:763–773
Tomé-Carneiro J, Gonzálvez M, Larrosa M et al (2012) One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am J Cardiol 110:356–363
Bhatt JK, Thomas S, Nanjan MJ (2012) Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res 32:537–541
Oldfield JE (1987) The two faces of selenium. J Nutr 117:2002–2008
Simmons TW, Jamall IS, Lockshin RA (1987) The effect of selenium deficiency on peroxidative injury in the house fly, Musca domestica. A role for glutathione peroxidase. FEBS Lett 218:251–254
Kim IY, Stadtman TC (1997) Inhibition of NF-kappaB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc Natl Acad Sci U S A 94:12904–12907
Ayaz M, Ozdemir S, Yaras N, Vassort G, Turan B (2005) Selenium-induced alterations in ionic currents of rat cardiomyocytes. Biochem Biophys Res Commun 327:163–173
Turan B, Desilets M, Acan LN, Hotomaroglu O, Vannier C, Vassort G (1996) Oxidative effects of selenite on rat ventricular contractility and Ca movements. Cardiovasc Res 32:351–361
Ugur M, Turan B (2001) Adenosine triphosphate alters the selenite-induced contracture and negative inotropic effect on cardiac muscle contractions. Biol Trace Elem Res 79:235–245
Ugur M, Ayaz M, Ozdemir S, Turan B (2002) Toxic concentrations of selenite shortens repolarization phase of action potential in rat papillary muscle. Biol Trace Elem Res 89:227–238
Battell ML, Delgatty HL, McNeill JH (1998) Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats. Mol Cell Biochem 179:27–34
Ayaz M, Can B, Ozdemir S, Turan B (2002) Protective effect of selenium treatment on diabetes-induced myocardial structural alterations. Biol Trace Elem Res 89:215–226
Aydemir-Koksoy A, Bilginoglu A, Sariahmetoglu M, Schulz R, Turan B (2010) Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. J Nutr Biochem 21:827–833
Bilginoglu A, Seymen A, Tuncay E et al (2009) Antioxidants but not doxycycline treatments restore depressed beta-adrenergic responses of the heart in diabetic rats. Cardiovasc Toxicol 9(1):21–29
Aydemir-Koksoy A, Turan B (2008) Selenium inhibits proliferation signaling and restores sodium/potassium pump function of diabetic rat aorta. Biol Trace Elem Res 126:237–245
Ezaki O (1990) The insulin-like effects of selenate in rat adipocytes. J Biol Chem 265:1124–1128
Becker DJ, Reul B, Ozcelikay AT, Buchet JP, Henquin JC, Brichard SM (1996) Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats. Diabetologia 39:3–11
McNeill JH, Delgatty HL, Battell ML (1991) Insulin-like effects of sodium selenate in streptozocin-induced diabetic rats. Diabetes 40:1675–1678
Li S, Li X, Li YL, Shao CH, Bidasee KR, Rozanski GJ (2007) Insulin regulation of glutathione and contractile phenotype in diabetic rat ventricular myocytes. Am J Physiol Heart Circ Physiol 292:H1619–H1629
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ayaz, M., Turan, B. (2014). A Critical Balance Between Oxidative Stress and Antioxidant Defense in Cardiovascular System Under Hyperglycemia: A Summary of Experimental Studies. In: Turan, B., Dhalla, N. (eds) Diabetic Cardiomyopathy. Advances in Biochemistry in Health and Disease, vol 9. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9317-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9317-4_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9316-7
Online ISBN: 978-1-4614-9317-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)